1. |
Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism[J]. Medicine, 2006, 85(5):253-262.
|
2. |
Konstantinides S, Kasper W. Pulmonary embolism[M]//Massie BM, Drexler H. Cardiology. London:Mosby International, 2001:18.1-18.10.
|
3. |
Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism[J]. N Engl J Med, 1992, 326(19):1240-1245.
|
4. |
Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism[J]. Lancet, 1992, 340(8824):873-876.
|
5. |
Jiménez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy[J]. Chest, 2007, 132(1):24-30.
|
6. |
Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2008, 29(18):2276-2315.
|
7. |
中华医学会呼吸病学分会. 肺血栓栓塞症的诊断与治疗指南(草案)[J]. 中华结核和呼吸杂志, 2001, 24(5):6-11.
|
8. |
PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)[J]. JAMA, 1990, 263(20):2753-2759.
|
9. |
Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction[J]. Circulation, 2000, 101(24):2817-2822.
|
10. |
Giannitsis E, Katus HA. Risk stratification in pulmonary embolism based on biomarkers and echocardiography[J]. Circulation, 2005, 112(11):1520-1521.
|
11. |
Goldhaber SZ, Elliott CG. Acute pulmonary embolism:part Ⅱ:risk stratication, treatment, and prevention[J]. Circulation, 2003, 108(23):2834-2838.
|
12. |
Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction[J]. J Am Coll Cardiol, 2000, 36(5):1632-1636.
|
13. |
Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction[J]. Circulation, 1991, 83(3):902-912.
|
14. |
Mikulewicz M, Lewczuk J. Importance of cardiac biomarkers in risk stratification in acute pulmonary embolism[J]. Cardiology, 2008, 15(1):17-20.
|
15. |
Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism:clinical outcomes in the Inte rnational Cooperative Pulmonary Embolism Registry (ICOPER)[J]. Lancet, 1999, 353(9162):1386-1389.
|
16. |
Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism[J]. Circulation, 2002, 106(10):1263-1268.
|
17. |
Horlander KT, Leeper KV. Troponin levels as a guide to treatment of pulmonary embolism[J]. Curr Opin Pulm Med, 2003, 9(5):374-377.
|
18. |
Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined——a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000, 21(18):1502-1513.
|
19. |
Douketis JD, Leeuwenkamp O, Grobara P, et al. The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism[J]. J Thromb Haemost, 2005, 3(3):508-513.
|
20. |
Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome[J]. Circulation, 2002, 106(23):2871-2872.
|
21. |
Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism[J]. Chest, 2003, 123(6):1947-1952.
|
22. |
Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay[J]. Clin Lab, 2001, 47(1-2):29-33.
|
23. |
Hobbs FD, Davis RC, Roalfe AK, et al. Reliability of N-terminal probrain natriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations[J]. BMJ, 2002, 324(7352):1498.
|
24. |
Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure[J]. Circulation, 2002, 105(20):2392-2397.
|
25. |
王洪兴, 张显峰, 佟倩. B型脑钠肽水平与急性肺栓塞严重性及预后的关系[J]. 中国老年学杂志, 2012, 32(4):812-813.
|
26. |
Kurose M, Yosimura M, Yasue H. Raised plasma BNP in patients with pulmonary thromboembolism[J]. Heart, 1997, 78(3):320-321.
|
27. |
Krüger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism[J]. Am Heart J, 2004, 147(1):60-65.
|
28. |
檀旦, 赵玉虹, 黄亚明. B型利钠肽对急性肺栓塞预后预测价值的Meta分析[J]. 中国循证医学杂志, 2011, 11(1):64-69.
|
29. |
de Lemos JA, Mcguire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease[J]. Lancet, 2003, 362(9380):316-322.
|